Literature DB >> 20693843

Chemokines: can effector cells be redirected to the site of the tumor?

Steven M Dubinett1, Jay M Lee, Sherven Sharma, James J Mulé.   

Abstract

Chemokines (ie, chemoattractant cytokines) are a family of small secreted molecules that mediate leukocyte migration. It is becoming increasingly more evident that chemokines play an integral role in the initiation of a specific immune response. With respect to cancer, chemokines are being studied for both their role in tumor biology and as promising immunotherapy candidates. We review several areas of chemokine importance in tumor immunity and discuss the experimental evidence that is leading to the clinical use of this cytokine family in new treatment approaches for patients with cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693843      PMCID: PMC3076643          DOI: 10.1097/PPO.0b013e3181eb33bc

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  55 in total

1.  Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway.

Authors:  Taoyong Chen; Jun Guo; Chaofeng Han; Mingjin Yang; Xuetao Cao
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

2.  Ectopic lymph nodes within human solid tumors.

Authors:  Domenico Coppola; James J Mulé
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Tumor transfected with CCL21 enhanced reactivity and apoptosis resistance of human monocyte-derived dendritic cells.

Authors:  Sha Wu; Wei Xing; Jiling Peng; Xiaomei Yuan; Xiaoping Zhao; Ping Lei; Wenhan Li; Min Wang; Huifen Zhu; Bo Huang; Liming Huang; Guanxin Shen
Journal:  Immunobiology       Date:  2007-11-28       Impact factor: 3.144

4.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

Review 5.  Chemokines, leukocyte trafficking, and inflammation.

Authors:  T J Schall; K B Bacon
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

6.  Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Authors:  Helena Harlin; Yuru Meng; Amy C Peterson; Yuanyuan Zha; Maria Tretiakova; Craig Slingluff; Mark McKee; Thomas F Gajewski
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

7.  CCR6 regulates the migration of inflammatory and regulatory T cells.

Authors:  Tomohide Yamazaki; Xuexian O Yang; Yeonseok Chung; Atsushi Fukunaga; Roza Nurieva; Bhanu Pappu; Natalia Martin-Orozco; Hong Soon Kang; Li Ma; Athanasia D Panopoulos; Suzanne Craig; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.

Authors:  Curtis J Henry; David A Ornelles; Latoya M Mitchell; Kristina L Brzoza-Lewis; Elizabeth M Hiltbold
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 9.  Maximizing dendritic cell migration in cancer immunotherapy.

Authors:  Pauline Verdijk; Erik H J G Aarntzen; Cornelis J A Punt; I Jolanda M de Vries; Carl G Figdor
Journal:  Expert Opin Biol Ther       Date:  2008-07       Impact factor: 4.388

10.  Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

Authors:  Satoko Matsumura; Baomei Wang; Noriko Kawashima; Steve Braunstein; Michelle Badura; Thomas O Cameron; James S Babb; Robert J Schneider; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

View more
  20 in total

1.  Production of Recombinant Chemokines and Validation of Refolding.

Authors:  Christopher T Veldkamp; Chad A Koplinski; Davin R Jensen; Francis C Peterson; Kaitlin M Smits; Brittney L Smith; Scott K Johnson; Christina Lettieri; Wallace G Buchholz; Joyce C Solheim; Brian F Volkman
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

Review 2.  Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.

Authors:  Melissa G Lechner; Sarah M Russell; Rikki S Bass; Alan L Epstein
Journal:  Immunotherapy       Date:  2011-11       Impact factor: 4.196

3.  Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.

Authors:  Domenico Coppola; Michael Nebozhyn; Farah Khalil; Hongyue Dai; Timothy Yeatman; Andrey Loboda; James J Mulé
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

4.  Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.

Authors:  Andrew Gabrielson; Yunan Wu; Hongkun Wang; Jiji Jiang; Bhaskar Kallakury; Zoran Gatalica; Sandeep Reddy; David Kleiner; Thomas Fishbein; Lynt Johnson; Eddie Island; Rohit Satoskar; Filip Banovac; Reena Jha; Jaydeep Kachhela; Perry Feng; Tiger Zhang; Anteneh Tesfaye; Petra Prins; Christopher Loffredo; John Marshall; Louis Weiner; Michael Atkins; Aiwu Ruth He
Journal:  Cancer Immunol Res       Date:  2016-03-11       Impact factor: 11.151

5.  Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.

Authors:  Jay M Lee; Mi-Heon Lee; Edward Garon; Jonathan W Goldman; Ramin Salehi-Rad; Felicita E Baratelli; Dörthe Schaue; Gerald Wang; Fran Rosen; Jane Yanagawa; Tonya C Walser; Ying Lin; Stacy J Park; Sharon Adams; Francesco M Marincola; Paul C Tumeh; Fereidoun Abtin; Robert Suh; Karen L Reckamp; Gina Lee; William D Wallace; Sarah Lee; Gang Zeng; David A Elashoff; Sherven Sharma; Steven M Dubinett
Journal:  Clin Cancer Res       Date:  2017-05-03       Impact factor: 12.531

6.  Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration.

Authors:  Dong Hyeok Kim; Chaerin Moon; Sang-Seok Oh; Soojong Park; Jin-Woo Jeong; Suk Kim; Hee Gu Lee; Hyung-Joo Kwon; Kwang Dong Kim
Journal:  Nucleic Acid Ther       Date:  2015-02-18       Impact factor: 5.486

7.  Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Authors:  Muthulekha Swamydas; Krista Ricci; Stephen L Rego; Didier Dréau
Journal:  Cell Adh Migr       Date:  2013-05-24       Impact factor: 3.405

8.  Dysfunction of Decidual Macrophages Is a Potential Risk Factor in the Occurrence of Preeclampsia.

Authors:  Miaomiao Rong; Xingyu Yan; Hongya Zhang; Chan Zhou; Cong Zhang
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma.

Authors:  Brittany J Poelaert; Svetlana Romanova; Shelby M Knoche; Madeline T Olson; Bailee H Sliker; Kaitlin Smits; Brittney L Dickey; Alexandra E J Moffitt-Holida; Benjamin T Goetz; Nuzhat Khan; Lynette Smith; Hamid Band; Aaron M Mohs; Donald W Coulter; Tatiana K Bronich; Joyce C Solheim
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

10.  12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

Authors:  Jane L Messina; David A Fenstermacher; Steven Eschrich; Xiaotao Qu; Anders E Berglund; Mark C Lloyd; Michael J Schell; Vernon K Sondak; Jeffrey S Weber; James J Mulé
Journal:  Sci Rep       Date:  2012-10-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.